Skip to main content
Erschienen in: Infection 6/2012

01.12.2012 | Clinical and Epidemiological Study

Causes of death among Danish HIV patients compared with population controls in the period 1995–2008

verfasst von: M. Helleberg, G. Kronborg, C. S. Larsen, G. Pedersen, C. Pedersen, J. Gerstoft, N. Obel

Erschienen in: Infection | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the mortality and causes of death in human immunodeficiency syndrome (HIV) patients with the background population.

Methods

All adult HIV patients treated in Danish HIV centers from 1995 to 2008 and 14 controls for each HIV patient were included. Age-adjusted mortality rates (MR) and mortality rate ratios (MRR) were estimated using direct standardization and Poisson regression analyses. Up to four contributory causes of death for each person were included in analyses of cause-specific MR.

Results

A total of 5,137 HIV patients and 71,918 controls were followed for 37,838 and 671,339 person-years (PY), respectively. Among non-injection drug use (IDU) HIV patients, the acquired immune deficiency syndrome (AIDS)-related MR/1,000 PY declined dramatically from 122.9 [95 % confidence interval (CI) 106.8–141.4] in 1995 to 5.0 (95 % CI 3.1–8.1) in 2008. The non-AIDS-related MR did not change substantially from 6.9 (95 % CI 3.8–12.5) to 5.6 (95 % CI 3.6–8.8). The MR of unnatural causes declined from 6.9 (95 % CI 3.8–12.5) to 2.7 (95 % CI 1.4–5.1). The MRR of infections declined from 46.6 (95 % CI 19.6–110.9) to 3.3 (95 % CI 1.6–6.6). The MRR of other natural causes of death remained constant.

Conclusions

After the introduction of highly active antiretroviral therapy (HAART), the AIDS-related mortality has decreased substantially, but the long-term exposure to HIV and HAART has not translated into increasing mortality from malignancy, cardiovascular, and hepatic diseases.
Literatur
1.
Zurück zum Zitat Vittinghoff E, Scheer S, O’Malley P, Colfax G, Holmberg SD, Buchbinder SP. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis. 1999;179:717–20.PubMedCrossRef Vittinghoff E, Scheer S, O’Malley P, Colfax G, Holmberg SD, Buchbinder SP. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis. 1999;179:717–20.PubMedCrossRef
2.
Zurück zum Zitat Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–60.PubMedCrossRef Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–60.PubMedCrossRef
3.
Zurück zum Zitat Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sørensen HT, et al. Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med. 2007;146:87–95.PubMed Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sørensen HT, et al. Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med. 2007;146:87–95.PubMed
4.
Zurück zum Zitat Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50:1387–96.CrossRef Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50:1387–96.CrossRef
5.
Zurück zum Zitat Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27–34.PubMedCrossRef Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27–34.PubMedCrossRef
6.
Zurück zum Zitat Friis-Møller N, Sabin CA, Weber R, d’Arminio Monforte A, El-Sadr WM, Reiss P, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993–2003.PubMedCrossRef Friis-Møller N, Sabin CA, Weber R, d’Arminio Monforte A, El-Sadr WM, Reiss P, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993–2003.PubMedCrossRef
7.
Zurück zum Zitat Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS. 2003;17:2479–86.PubMedCrossRef Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS. 2003;17:2479–86.PubMedCrossRef
8.
Zurück zum Zitat Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med. 2009;17:118–23.PubMed Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med. 2009;17:118–23.PubMed
9.
Zurück zum Zitat Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sørensen HT. Cohort profile: the Danish HIV cohort study. Int J Epidemiol. 2009;38:1202–6.PubMedCrossRef Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sørensen HT. Cohort profile: the Danish HIV cohort study. Int J Epidemiol. 2009;38:1202–6.PubMedCrossRef
11.
Zurück zum Zitat Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull. 1999;46:354–7.PubMed Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull. 1999;46:354–7.PubMed
12.
Zurück zum Zitat World Health Organization (WHO). International statistical classification of diseases and related health problems, 10th revision. Geneva: WHO; 1993. World Health Organization (WHO). International statistical classification of diseases and related health problems, 10th revision. Geneva: WHO; 1993.
13.
Zurück zum Zitat Curtin LR, Klein RJ. Direct standardization (age-adjusted death rates), vol. 6. Atlanta: Centers for Disease Control and Prevention/National Center for Health Statistics; 1995. p. 1–10. Curtin LR, Klein RJ. Direct standardization (age-adjusted death rates), vol. 6. Atlanta: Centers for Disease Control and Prevention/National Center for Health Statistics; 1995. p. 1–10.
14.
Zurück zum Zitat Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005;6:99–106.PubMedCrossRef Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005;6:99–106.PubMedCrossRef
15.
Zurück zum Zitat Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34:121–30.PubMedCrossRef Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34:121–30.PubMedCrossRef
16.
Zurück zum Zitat Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397–406.PubMed Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397–406.PubMed
17.
Zurück zum Zitat Aldaz P, Moreno-Iribas C, Egüés N, Irisarri F, Floristan Y, Sola-Boneta J, et al. Mortality by causes in HIV-infected adults: comparison with the general population. BMC Public Health. 2011;11:300.PubMedCrossRef Aldaz P, Moreno-Iribas C, Egüés N, Irisarri F, Floristan Y, Sola-Boneta J, et al. Mortality by causes in HIV-infected adults: comparison with the general population. BMC Public Health. 2011;11:300.PubMedCrossRef
18.
Zurück zum Zitat Helleberg M, Engsig FN, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Retention in a public healthcare system with free access to treatment: a Danish nationwide HIV cohort study. AIDS. 2012;26:741–8.PubMedCrossRef Helleberg M, Engsig FN, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Retention in a public healthcare system with free access to treatment: a Danish nationwide HIV cohort study. AIDS. 2012;26:741–8.PubMedCrossRef
19.
Zurück zum Zitat Obel N, Omland LH, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS One. 2011;6:e22698.PubMedCrossRef Obel N, Omland LH, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS One. 2011;6:e22698.PubMedCrossRef
20.
Zurück zum Zitat Engsig FN, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, et al. Lung cancer in HIV patients and their parents: a Danish cohort study. BMC Cancer. 2011;11:272.PubMedCrossRef Engsig FN, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, et al. Lung cancer in HIV patients and their parents: a Danish cohort study. BMC Cancer. 2011;11:272.PubMedCrossRef
21.
Zurück zum Zitat Palella FJ Jr, Phair JP. Cardiovascular disease in HIV infection. Curr Opin HIV AIDS. 2011;6:266–71.PubMedCrossRef Palella FJ Jr, Phair JP. Cardiovascular disease in HIV infection. Curr Opin HIV AIDS. 2011;6:266–71.PubMedCrossRef
22.
Zurück zum Zitat Riddler SA, Li X, Otvos J, Post W, Palella F, Kingsley L, et al. Antiretroviral therapy is associated with an atherogenic lipoprotein phenotype among HIV-1-infected men in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2008;48:281–8.PubMedCrossRef Riddler SA, Li X, Otvos J, Post W, Palella F, Kingsley L, et al. Antiretroviral therapy is associated with an atherogenic lipoprotein phenotype among HIV-1-infected men in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2008;48:281–8.PubMedCrossRef
23.
Zurück zum Zitat Rasmussen LD, Omland LH, Pedersen C, Gerstoft J, Kronborg G, Jensen J, et al. Risk of myocardial infarction in parents of HIV-infected individuals: a population-based cohort study. BMC Infect Dis. 2010;10:169.PubMedCrossRef Rasmussen LD, Omland LH, Pedersen C, Gerstoft J, Kronborg G, Jensen J, et al. Risk of myocardial infarction in parents of HIV-infected individuals: a population-based cohort study. BMC Infect Dis. 2010;10:169.PubMedCrossRef
24.
Zurück zum Zitat Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med. 2003;348:702–10.PubMedCrossRef Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med. 2003;348:702–10.PubMedCrossRef
25.
Zurück zum Zitat Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203.PubMedCrossRef Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203.PubMedCrossRef
26.
Zurück zum Zitat Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203:780–90.PubMedCrossRef Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203:780–90.PubMedCrossRef
27.
Zurück zum Zitat Baker JV, Lundgren JD. Cardiovascular implications from untreated human immunodeficiency virus infection. Eur Heart J. 2011;32:945–51.PubMedCrossRef Baker JV, Lundgren JD. Cardiovascular implications from untreated human immunodeficiency virus infection. Eur Heart J. 2011;32:945–51.PubMedCrossRef
28.
Zurück zum Zitat Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120–6.PubMedCrossRef Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120–6.PubMedCrossRef
Metadaten
Titel
Causes of death among Danish HIV patients compared with population controls in the period 1995–2008
verfasst von
M. Helleberg
G. Kronborg
C. S. Larsen
G. Pedersen
C. Pedersen
J. Gerstoft
N. Obel
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Infection / Ausgabe 6/2012
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0293-y

Weitere Artikel der Ausgabe 6/2012

Infection 6/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.